ISPOR HEALTH TECHNOLOGY ASSESSMENT AND EVIDENCE-BASED DECISIONS SPECIAL INTEREST GROUP (HTA-EBD)

GLOBAL HEALTH TECHNOLOGY ASSESSMENTS USED IN HEALTH CARE REIMBURSEMENT WORKING GROUP

Co-chairs:
Stefan Holmstrom BSc, MSc
, Director Project Management, HE&OR, NicOx SA, Antipolis- cedex, France
Kevin Mayo PhD, Vice President Market Access Solutions, Bridgehead International Consulting, Denville, NJ, USA

Leadership Group
Annie Chicoye, Senior Principal Director Pricing & Market Access IMS Consulting, Puteaux cedex, France
Hans Middelhoven PhD, F. Hoffmann – La Roche Ltd., Basel, Switzerland
Mark Nuijten PhD, MD, MBA Eramus University, Rotterdam, The Netherlands
W. Neil Palmer, Vice-President, Pricing and Reimbursement, RTI Health Solutions, Ottawa, Canada
Carolyn Steeds BSc, Independent Consultant, Carolyn Steeds Consulting, Motherwell, Scotland
Rebecca Townsend BSc, Project Director, Evidence Research Unit, Macclesfield, UK
Christoph Vauth MSc, PhD Student, University of Hannover / IVBL, Hanover, Germany
Konrad RB Wallerstein, Adelphi Focus, Doylestown, PA, USA
Feng Zeng PhD, Health Economist, MedImpact Healthcare Systems, San Diego, CA

Objectives:
  1. To develop a global review of available health technology assessment information
  2. To develop a roadmap of health technology assessment information at the ISPOR website for health care decision-makers and payers.
Achievements:

Country Contributors

Canada W. Neil Palmer, Vice-President, Pricing and Reimbursement, RTI Health Solutions, Ottawa, Canada
China Feng Zeng PhD, Health Economist, MedImpact Healthcare Systems, San Diego, CA
France Annie Chicoye, Senior Principal Director Pricing & Market Access IMS Consulting, Puteaux cedex, France
Germany Christoph Vauth MSc, PhD Student, University of Hannover / IVBL, Hanover, Germany
Mark Nuijten PhD, MD, MBA Eramus University, Rotterdam, The Netherlands
Italy Hans Middlehoven PhD, F. Hoffmann – La Roche Ltd., Basel, Switzerland
The Netherlands Mark Nuijten PhD, MD, MBA Eramus University, Rotterdam, The Netherlands
Scotland Carolyn Steeds BSc, Independent Consultant, Carolyn Steeds Consulting, Motherwell, Scotland
Spain Hans Middlehoven PhD , F. Hoffmann – La Roche Ltd., Basel, Switzerland
UK Rebecca Townsend BSc, Project Director, Evidence Research Unit, Macclesfield, UK

 

Global HTA used in Health Care Reimbursement WG Members Access Only

  How to login

User name: first part of the email address (before @)
e.g. for jdoe@ispor.org it should be jdoe)
Password: ISPOR Member ID.

  Click here for login help

 


HTA in EBD SIG | Special Interest Groups - index
 

Contact ISPOR @ info@ispor.org  |  View Legal Disclaimer
©2008 International Society for Pharmacoeconomics and Outcomes Research.
All rights reserved under International and Pan-American Copyright Conventions.
 
Website design by Eagle Systems USA, Inc.